Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Episode 30 with Dr. Seema Tiwari-Woodruff on estrogenic compounds and MS
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.
Episode 13 with Professor Alan Thompson on the International Progressive MS Alliance.
Spectrophotometric Determination of Serum Copper with Biscyclohexanoneoxalyldihydrazone
SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
Pregnancy and multiple sclerosis.
MS clinical trials: what can subgroup analyses teach us?
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
MS Research Roundup: An Introduction
Extracellular Cues Influencing Oligodendrocyte Differentiation and (Re)myelination.
Episode 12 with Professor Gavin Giovannoni on the potential for finding a cure for MS.
Keystone Symposium: Gut Microbiota Modulation of Host Physiology: The Search for Mechanism
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
MSGene
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
A New Colour Reaction on Copper and Certain Carbonyl Compounds
MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
American Academy of Neurology: Breakthroughs in Neurology
Oral BG-12 (dimethyl fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression in DEFINE Phase 3 clinical trial
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.
GlaxoSmithKline Product Development Pipeline
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
Pages
« first
‹ previous
…
53
54
55
56
57
58
59
60
61
…
next ›
last »